PolarityTE, Inc. (PTE): Price and Financial Metrics


PolarityTE, Inc. (PTE): $0.71

0.02 (+2.40%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add PTE to Watchlist
Sign Up

Industry: Biotech


Ranked

of

in industry

PTE POWR Grades

  • PTE scores best on the Growth dimension, with a Growth rank ahead of 95.1% of US stocks.
  • The strongest trend for PTE is in Sentiment, which has been heading up over the past 160 days.
  • PTE ranks lowest in Stability; there it ranks in the 2nd percentile.

PTE Stock Summary

  • POLARITYTE INC's market capitalization of $5,114,664 is ahead of merely 1.22% of US-listed equities.
  • With a year-over-year growth in debt of -76.99%, POLARITYTE INC's debt growth rate surpasses merely 2.59% of about US stocks.
  • As for revenue growth, note that PTE's revenue has grown -84.47% over the past 12 months; that beats the revenue growth of merely 1.61% of US companies in our set.
  • If you're looking for stocks that are quantitatively similar to POLARITYTE INC, a group of peers worth examining would be DZSI, SCKT, ACLS, ALLT, and SQL.
  • Visit PTE's SEC page to see the company's official filings. To visit the company's web site, go to www.polarityte.com.

PTE Valuation Summary

  • In comparison to the median Healthcare stock, PTE's price/sales ratio is 35% higher, now standing at 2.7.
  • Over the past 217 months, PTE's price/sales ratio has gone up 0.2.

Below are key valuation metrics over time for PTE.

Stock Date P/S P/B P/E EV/EBIT
PTE 2022-12-05 2.7 0.3 -0.3 0.7
PTE 2022-12-02 2.7 0.3 -0.3 0.7
PTE 2022-12-01 2.8 0.3 -0.3 0.7
PTE 2022-11-30 2.7 0.3 -0.3 0.7
PTE 2022-11-29 2.7 0.3 -0.3 0.7
PTE 2022-11-28 2.9 0.3 -0.3 0.7

PTE's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • PTE has a Quality Grade of C, ranking ahead of 34.18% of graded US stocks.
  • PTE's asset turnover comes in at 0.289 -- ranking 158th of 682 Pharmaceutical Products stocks.
  • BTX, RMTI, and KPTI are the stocks whose asset turnover ratios are most correlated with PTE.

The table below shows PTE's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 0.289 0.569 -2.653
2021-03-31 0.276 0.563 -2.847
2020-12-31 0.194 0.563 -2.485
2020-09-30 0.148 0.599 -2.425
2020-06-30 0.100 0.587 -2.675
2020-03-31 0.075 0.567 -2.684

PTE Price Target

For more insight on analysts targets of PTE, see our PTE price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $2.25 Average Broker Recommendation 1.67 (Moderate Buy)

PTE Stock Price Chart Interactive Chart >

Price chart for PTE

PTE Price/Volume Stats

Current price $0.71 52-week high $20.75
Prev. close $0.69 52-week low $0.61
Day low $0.66 Volume 75,245
Day high $0.72 Avg. volume 231,646
50-day MA $0.73 Dividend yield N/A
200-day MA $2.81 Market Cap 5.12M

PolarityTE, Inc. (PTE) Company Bio


PolarityTE, Inc. operates as a translational regenerative medicine company. The Company develops functionally polarized human tissues to improve clinical medicine and biomedical research. PolarityTE offers its services in the United States.


PTE Latest News Stream


Event/Time News Detail
Loading, please wait...

PTE Latest Social Stream


Loading social stream, please wait...

View Full PTE Social Stream

Latest PTE News From Around the Web

Below are the latest news stories about POLARITYTE INC that investors may wish to consider to help them evaluate PTE as an investment opportunity.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday

Welcome back and get ready for the week with a breakdown of the biggest pre-market stock movers worth knowing about on Monday morning!

William White on InvestorPlace | November 14, 2022

PolarityTE Reports Third Quarter 2022 Financial Results and Provides Business Update

SALT LAKE CITY, Nov. 10, 2022 /PRNewswire/ -- PolarityTE, Inc. (Nasdaq: PTE) a biotechnology company developing regenerative tissue products and biomaterials, today provided a business update and reported financial results for the quarterly period ended September 30, 2022. Recent Business…

PR Newswire | November 10, 2022

PolarityTE GAAP EPS of -$0.47

PolarityTE press release (PTE): Q3 GAAP EPS of -$0.47.The Company had cash and cash equivalents of $16.1 million and working capital of $15.7 million at September 30, 2022.

Seeking Alpha | November 10, 2022

PolarityTE Shares Jump After Non-Binding Buyout Offer Of $1.25/Share

PolarityTE Inc (NASDAQ: PTE ) shares are surging after it received an unsolicited, non-binding offer (followed by an amended offer) from Michael Brauser to acquire all of the outstanding common stock of the company not owned by him for $1.25 per share in cash . The company''s board and a special committee will carefully review the terms and conditions of the … Full story available on Benzinga.com

Benzinga | November 9, 2022

PolarityTE Confirms Receipt of Unsolicited, Non-Binding Offer to Acquire the Company

SALT LAKE CITY, Nov. 9, 2022 /PRNewswire/ -- PolarityTE, Inc. (Nasdaq: PTE), a biotechnology company developing regenerative tissue products and biomaterials, today confirmed that on November 1, 2022, it received an unsolicited, non-binding offer (followed by an amended offer on November…

PR Newswire | November 9, 2022

Read More 'PTE' Stories Here

PTE Price Returns

1-mo -4.95%
3-mo -19.95%
6-mo -68.72%
1-year -93.91%
3-year -98.96%
5-year -99.90%
YTD -95.16%
2021 -13.68%
2020 -73.85%
2019 -80.73%
2018 -41.88%
2017 616.36%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.7451 seconds.